Teva Pharmaceutical Industries Income Statement (2009-2026) | TEVA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	3.91B	3.89B	4.10B	3.66B	3.79B	3.60B	3.88B	3.66B	3.88B	3.85B	4.46B	3.82B	4.16B	4.33B	2.90B	3.89B	4.18B	4.48B	4.71B	3.98B
Cost of Revenue (Quarter)	0.61B	0.60B	2.05B	1.92B	0.59B	0.54B	2.11B	2.08B	2.08B	2.00B	0.61B	2.05B	2.14B	2.18B	6.59B	0.62B	2.07B	2.18B	2.06B	0.70B
Gross Profit (Quarter)	1.87B	1.79B	2.05B	1.74B	1.79B	1.67B	1.77B	1.58B	1.80B	1.85B	2.42B	1.77B	2.02B	2.15B	2.12B	1.88B	2.10B	2.30B	2.66B	1.97B
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	0.25B	0.22B	0.24B	0.23B	0.23B	0.17B	0.21B	0.23B	0.24B	0.25B	0.23B	0.24B	0.27B	0.24B	0.25B	0.25B	0.24B	0.26B	0.27B	0.22B
Selling, General & Administrative (Quarter)	0.24B	0.29B	0.28B	0.30B	0.31B	0.28B	0.29B	0.30B	0.31B	0.27B	0.29B	0.28B	0.28B	0.30B	0.30B	0.30B	0.30B	0.32B	0.37B	0.30B
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)	0.04B	0.03B	0.03B	0.05B	0.03B	0.00B	0.02B	0.00B	0.03B	0.01B	0.01B	-0.00B	0.00B	0.02B	-0.01B	-0.01B	-0.00B	-0.01B	-0.00B	0.01B
Operating Expenses (Quarter)	0.49B	0.51B	0.52B	0.52B	0.54B	0.46B	0.50B	0.53B	0.55B	0.52B	0.52B	0.52B	0.55B	0.54B	0.55B	0.54B	0.55B	0.57B	0.63B	0.53B
Operating Income (Quarter)	0.58B	0.62B	0.08B	-0.71B	-0.97B	0.42B	-0.94B	-0.01B	-0.65B	0.34B	0.76B	-0.22B	-0.01B	-0.05B	-0.03B	0.52B	0.46B	0.88B	0.30B	0.65B
EBIT (Quarter)	0.58B	0.62B	0.08B	-0.71B	-0.97B	0.42B	-0.94B	-0.01B	-0.65B	0.34B	0.76B	-0.22B	-0.01B	-0.05B	-0.03B	0.52B	0.46B	0.88B	0.30B	0.65B
Non-operating items
Non Operating Investment Income (Quarter)
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)	-0.27B	-0.24B	-0.25B	-0.26B	-0.21B	-0.25B	-0.24B	-0.26B	-0.27B	-0.28B	-0.25B	-0.25B	-0.24B	-0.27B	-0.22B	-0.23B	-0.25B	-0.24B	-0.22B	-0.22B
Net income details
EBT (Quarter)	0.31B	0.38B	-0.17B	-0.97B	-1.18B	0.17B	-1.19B	-0.27B	-0.92B	0.06B	0.51B	0.47B	-0.25B	-0.32B	-0.25B	0.29B	0.20B	0.65B	0.08B	0.44B
Tax Provisions (Quarter)	0.10B	0.08B	-0.02B	0.00B	-0.90B	0.11B	0.15B	-0.02B	-0.02B	-0.01B	0.04B	-0.05B	0.63B	0.07B	0.03B	0.07B	-0.08B	0.21B	-0.39B	0.07B
Profit After Tax (Quarter)	0.21B	0.29B	-0.19B	-0.95B	-0.28B	0.06B	-1.33B	-0.25B	-0.87B	0.07B	0.46B	-0.42B	-0.87B	-0.44B	-0.28B	0.21B	0.28B	0.43B	0.48B	0.37B
Equity Income (Quarter)	0.01B	-0.01B		0.02B		-0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B		-0.00B	0.00B	0.00B	0.01B	-0.00B
Net Income - Minority (Quarter)	-0.99B	-0.98B	-0.97B	-0.92B	-0.79B	-0.75B	-0.79B	-0.75B	-0.66B	-0.58B	-0.62B	-0.27B	-0.20B	-0.32B	-0.01B	-0.01B	-0.01B	-0.00B	-0.00B	-0.00B
Income from Non-Controlling Interests (Quarter)	0.01B	0.01B	0.01B	0.00B	-0.03B	0.00B	-0.03B	-0.03B	-0.04B	0.01B	0.00B	-0.28B	-0.03B	0.05B	-0.06B	0.01B		0.00B
Income from Continuing Operations (Quarter)	0.21B	0.31B	-0.15B	-0.97B	-0.28B	0.06B	-1.33B	-0.25B	-0.91B	0.08B	0.47B	0.52B	-0.88B	-0.39B	-0.28B	0.22B	0.28B	0.43B	0.47B	0.37B
Consolidated Net Income (Quarter)	0.21B	0.31B	-0.15B	-0.97B	-0.28B	0.06B	-1.33B	-0.25B	-0.91B	0.08B	0.47B	0.52B	-0.88B	-0.39B	-0.28B	0.22B	0.28B	0.43B	0.47B	0.37B
Income towards Parent Company (Quarter)	-0.78B	-0.68B	-1.12B	-1.89B	-1.07B	-0.69B	-2.13B	-1.00B	-1.56B	-0.51B	-0.15B	0.25B	-1.08B	-0.71B	-0.28B	0.21B	0.27B	0.43B	0.47B	0.37B
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-0.78B	-0.68B	-1.12B	-1.89B	-1.07B	-0.69B	-2.13B	-1.00B	-1.56B	-0.51B	-0.15B	0.25B	-1.08B	-0.71B	-0.28B	0.21B	0.27B	0.43B	0.47B	0.37B
Additional items
EPS (Basic) (Quarter)	0.19	0.26	-0.14	-0.86	-0.23	0.05	-1.17	-0.20	-0.78	0.06	0.41	-0.12	-0.75	-0.39	-0.19	0.19	0.25	0.38	0.42	0.32
EPS (Weighted Average and Diluted) (Quarter)	0.19	0.26	-0.14	-0.86	-0.23	0.05	-1.17	-0.20	-0.78	0.06	0.41	-0.12	-0.75	-0.39	-0.19	0.18	0.24	0.37	0.41	0.31
Shares Outstanding (Weighted Average) (Quarter)	1.10B	1.10B	1.10B	1.11B	1.11B	1.11B	1.11B	1.11B	1.12B	1.12B	1.12B	1.12B	1.13B	1.13B	1.13B	1.14B	1.14B	1.15B	1.15B	1.16B
Shares Outstanding (Diluted Average) (Quarter)	1.11B	1.11B	1.11B	1.11B	1.11B	1.12B	1.11B	1.11B	1.12B	1.14B	1.12B	1.12B	1.13B	1.13B	1.13B	1.16B	1.16B	1.16B	1.16B	1.18B
EBITDA (Quarter)	0.58B	0.62B	0.08B	-0.71B	-0.97B	0.42B	-0.94B	-0.01B	-0.65B	0.34B	0.76B	-0.22B	-0.01B	-0.05B	-0.03B	0.52B	0.46B	0.88B	0.30B	0.65B
Interest Expenses (Quarter)
Tax Rate (Quarter)	31.82%	19.90%	13.71%	-0.21%	76.40%	62.57%	-12.57%	6.99%	1.73%	-18.75%	8.09%	-11.13%	-256.10%	-21.30%	-11.34%	25.17%	-38.42%	33.13%	-487.50%	15.33%

Research Tools

Teva Pharmaceutical Industries Income Statement (2009-2026) | TEVA

Create an account

Sign In

Reset Password